Medtronic's Resolute Integrity
This article was originally published in The Gray Sheet
Executive Summary
Firm announces CE mark clearance and international roll-out of its Resolute Integrity zotarolimus-eluting coronary stent system on Aug. 30. Shipments will start the week of Sept. 6. The device incorporates the MicroTrac delivery system and continuous sinusoid technology to offer improved deliverability and conformability while retaining the same drug and BioLinx polymer of the original Resolute drug-eluting stent, the firm explains. Continuous sinusoid technology enables the stent to be made from a single wire. Medtronic notes it also will pursue U.S. approval